Demographic and healthcare vulnerabilities driving health tech developments

Netherlands Innovation Network Life Sciences & Health Leave a Comment

If current trends continue, by 2029 China’s population will peak at 1.44 billion, with dramatically imbalanced ratios of young to old (4 grandparents, 2 parents, 1 child) putting unprecedented pressure on younger generations. This dependency ratio (non-working: working people) is set to increase from 42% to 67% by 2050, by when a quarter of the Chinese population (350 million) will …

China’s Vaccine Program and mRNA Technology

Netherlands Innovation Network Life Sciences & Health Leave a Comment

Globally, a process of immunization has started. The first Covid-19 vaccines have been approved by national and regional medicinal drug supervisors such as the UK MHRA, US FDA, and the EU EMA (The Economist, 2020). The Netherlands does not have a big biotech/pharma company (anymore) and is therefore not a leading contender in vaccine production.  Traditionally, vaccines put (a part …

Interview with Wang Yiding

Netherlands Innovation Network Academics, Interviews, Life Sciences & Health Leave a Comment

by Claire Selbeck Mr Wang is an alumnus of two Dutch universities; Wageningen University and the Delft University of Technology. In the past, he has worked at Sinovac and he currently works at Pfizer, as the Senior Manager Vaccine GCMC China. In Beijing, the Innovation Network had the opportunity to meet with him and hear more about his studies in …

Cleveringa Lecture in Shanghai about the pharmaceutical industry

Netherlands Innovation Network Academics, Life Sciences & Health Leave a Comment

The Netherlands Innovation Network China organized their yearly Cleveringa Lecture at the residence of the Consulate-General in Shanghai. The lecture was given by Henk Jan Out, writer of the book ‘Long Live the Medicine’ (Lang leve het Geneesmiddel) and CSO of Ferring Pharmaceuticals in Shanghai. The topic of his lecture was “Pharmaceutical Companies: Creative Innovators or Crooked Moneymakers?” and was …

#2 Antimicrobial Resistance (AMR) – 3 innovative scientific approaches

Netherlands Innovation Network Life Sciences & Health, Podcast Leave a Comment

The world is fighting two pandemics at the same time – COVID19 and the silent pandemic of antimicrobial resistance (AMR). AMR occurs when bacteria become resistant to antibiotics, making their infections harder to treat. In Europe, approximately 25.000 people die every year because of drug resistant infections. It is estimated that AMR will kill an extra 10 million people globally by 2050. In this episode we …

#1 Antimicrobial Resistance (AMR) – introduction from CN and NL

Netherlands Innovation Network Life Sciences & Health, Podcast 1 Comment

The world is fighting two pandemics at the same time – COVID19 and the silent pandemic of antimicrobial resistance (AMR). AMR occurs when bacteria become resistant to antibiotics, making their infections harder to treat. In Europe, approximately 25.000 people die every year because of drug resistant infections. It is estimated that AMR will kill an extra 10 million people globally by 2050. In this episode we …

Life Sciences and Health webinar

Netherlands Innovation Network Life Sciences & Health, Sino-Dutch collaboration Leave a Comment

Nuffic Neso China, the representative office of Dutch higher education in China, is organizing the Orange Expert Webinar of Studying and Doing Research in the Netherlands with a focus on life sciences and health. The Science & Technology Counsellor at the Embassy of the Netherlands, Taake Manning, will open the webinar and will give an introduction to the life sciences …

Augmented AI for future disease surveillance: how AI can help prevent future pandemics

Netherlands Innovation Network Life Sciences & Health Leave a Comment

Emerging pathogens are a major threat to the public health. Over the past decades many scientists have warned us about new conditions that could lead to the introduction of new, potentially devastating pathogens. Despite the warnings, it is clear humans have failed to respond adequately to the pandemic which started in China in December 2019 infecting at the time of …

SEMINAR: Balancing regulation & innovation: transit of EMA to Amsterdam

Netherlands Innovation Network China Life Sciences & Health Leave a Comment

Seminar on the occasion of the transit of the European Medicines Agency to Amsterdam (EMA), 27th & 29th of May The seminar brings you a view from regulators, academia and industry on the necessity of maintaining the balance between regulation and innovation and will give you an update on the latest information on the transit of the EMA from the …

Regenerative Medicine in China

Anouk van der Steen Life Sciences & Health Leave a Comment

Regenerative Medicine in China Within Health Sciences, Regenerative Medicine is an area that China excels in. Research mostly happens in universities across the country, but it is to be expected that the Chinese Academy of Sciences will take a bigger share in this research. Patent analyses suggest corporate innovation is still limited compared to other countries. Therefore, Dutch interests in …